Upstream Bio, Inc.
UPB
$8.39
-$0.57-6.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.37M | 2.21M | 2.22M | 2.30M | 2.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.37M | 2.21M | 2.22M | 2.30M | 2.38M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.37M | 2.21M | 2.22M | 2.30M | 2.38M |
| SG&A Expenses | 17.17M | 15.24M | 13.39M | 12.04M | 10.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.13M | 67.98M | 58.49M | 50.49M | 42.49M |
| Operating Income | -77.76M | -65.78M | -56.27M | -48.19M | -40.11M |
| Income Before Tax | -62.81M | -53.40M | -40.51M | -30.52M | -20.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -62.81 | -53.40 | -40.51 | -30.52 | -20.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -62.81M | -53.40M | -40.51M | -30.52M | -20.54M |
| EBIT | -77.76M | -65.78M | -56.27M | -48.19M | -40.11M |
| EBITDA | -77.68M | -65.72M | -56.21M | -48.13M | -40.05M |
| EPS Basic | -19.16 | -23.71 | -18.87 | -16.04 | -13.22 |
| Normalized Basic EPS | -9.18 | -11.37 | -8.72 | -6.55 | -4.39 |
| EPS Diluted | -19.16 | -23.71 | -18.87 | -16.04 | -13.22 |
| Normalized Diluted EPS | -9.18 | -11.37 | -8.72 | -6.55 | -4.39 |
| Average Basic Shares Outstanding | 54.45M | 11.73M | 11.66M | 11.60M | 11.54M |
| Average Diluted Shares Outstanding | 54.45M | 11.73M | 11.66M | 11.60M | 11.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |